Literature DB >> 12552135

Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation.

Mark A McCoy1, Jennifer J Gesell, Mary M Senior, Daniel F Wyss.   

Abstract

The stabilization of p53 against Mdm2-mediated degradation is an important event in DNA damage response. Initial models of p53 stabilization focused on posttranslational modification of p53 that would disrupt the p53-Mdm2 interaction. The N-terminal regions of both p53 and Mdm2 are modified in vivo in response to cellular stress, suggesting that modifications to Mdm2 also may affect the p53-Mdm2 interaction. Our NMR studies of apo-Mdm2 have found that, in addition to Mdm2 residues 25-109 that form the well ordered p53-binding domain that was observed in the p52-Mdm2 complex, Mdm2 residues 16-24 form a lid that closes over the p53-binding site. The Mdm2 lid, which is strictly conserved in mammals, may help to stabilize apo-Mdm2. It also competes weakly with peptidic and nonpeptidic antagonists. Modifications to the Mdm2 lid may disrupt p53-Mdm2 binding leading to p53 stabilization. Mdm2 and Mdm4 possess nearly identical p53-binding domains but different lids suggesting that lid modifications may select for p53 binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552135      PMCID: PMC149886          DOI: 10.1073/pnas.0334477100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Regulation of the p53 tumor suppressor protein.

Authors:  M Oren
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation.

Authors:  C Blattner; E Tobiasch; M Litfen; H J Rahmsdorf; P Herrlich
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

4.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.

Authors:  T Unger; R V Sionov; E Moallem; C L Yee; P M Howley; M Oren; Y Haupt
Journal:  Oncogene       Date:  1999-05-27       Impact factor: 9.867

7.  Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells.

Authors:  J Abraham; D Spaner; S Benchimol
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

8.  Regulation of p53 function and stability by phosphorylation.

Authors:  M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

9.  Mdm2 association with p53 targets its ubiquitination.

Authors:  S Y Fuchs; V Adler; T Buschmann; X Wu; Z Ronai
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

10.  Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.

Authors:  D A Freedman; A J Levine
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more
  29 in total

1.  Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.

Authors:  Constantinos G Neochoritis; Jack Atmaj; Aleksandra Twarda-Clapa; Ewa Surmiak; Lukasz Skalniak; Lisa-Maria Köhler; Damian Muszak; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Barbara Beck; Tad A Holak; Alexander Dömling
Journal:  Eur J Med Chem       Date:  2019-08-06       Impact factor: 6.514

2.  Transient protein states in designing inhibitors of the MDM2-p53 interaction.

Authors:  Michal Bista; Siglinde Wolf; Kareem Khoury; Kaja Kowalska; Yijun Huang; Ewa Wrona; Marcelino Arciniega; Grzegorz M Popowicz; Tad A Holak; Alexander Dömling
Journal:  Structure       Date:  2013-10-24       Impact factor: 5.006

3.  Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.

Authors:  Erin G Worrall; Bartosz Wawrzynow; Liam Worrall; Malcolm Walkinshaw; Kathryn L Ball; Ted R Hupp
Journal:  J Chem Biol       Date:  2009-05-16

4.  What induces pocket openings on protein surface patches involved in protein-protein interactions?

Authors:  Susanne Eyrisch; Volkhard Helms
Journal:  J Comput Aided Mol Des       Date:  2008-09-06       Impact factor: 3.686

5.  Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.

Authors:  Changyou Zhan; Kristen Varney; Weirong Yuan; Le Zhao; Wuyuan Lu
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

6.  Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.

Authors:  Bing Shan; Da-Wei Li; Lei Brüschweiler-Li; Rafael Brüschweiler
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 7.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

8.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931

9.  Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.

Authors:  Shubhra Ghosh Dastidar; David P Lane; Chandra S Verma
Journal:  BMC Bioinformatics       Date:  2009-12-03       Impact factor: 3.169

10.  MDM4 (MDMX) and its Transcript Variants.

Authors:  F Mancini; G Di Conza; F Moretti
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.